11/26/2012 1:06PM EDT
Kip Frey is an entrepreneur, venture capitalist, and educator. He has served as CEO of several start-up companies, and as a partner at venture capital firm Intersouth Partners. He is currently President and CEO of Canines, Inc., an early-stage company focused on animal cognition, which he founded with Duke anthropology professor Brian Hare. He has also held senior positions on the management teams and boards of companies leveraging media and intellectual property.
Prior to joining Intersouth as a venture capitalist in 2000, Frey ran several venture-backed companies. From 1994 to 1998 he served as Executive Vice President and General Counsel of Ventana Communications Group, having sold the company in 1994 to Thomson Corporation. In 1998 he became President of Accipiter, Inc. and sold the company to CMGI, Inc., structuring the transaction so that its ultimate value exceeded $500 million.
Later that year Frey became President and CEO of OpenSite Technologies, Inc., which was acquired in 2000 by Siebel Systems for $542 million. OpenSite was named NCEITA Software Company of the Year in 1999 and Frey was honored by Digital South Magazine as the Southeast’s top entrepreneurial CEO. He received the Council for Entrepreneurial Development’s Entrepreneurial Excellence Award in 2000.
Frey is a lawyer by training and practiced intellectual property law for five years before joining Turner Broadcasting System in 1990. While at Turner he ran several business units and contributed to the acquisition of Castle Rock Entertainment, the formation of the Cartoon Network, and the construction of the MGM Grand Hotel and Casino.
Frey has taught classes at Duke University since 1994 and has held appointments as Professor of the Practice at Sanford School of Public Policy, Duke Law School and the Fuqua School of Business. As Director of the Law & Entrepreneurship Program at Duke Law School, Frey teaches entrepreneurial management, intellectual property law and policy. Starting June 2017, he will be the director for the Innovation & Entrepreneurship Initiative.
He currently serves on the boards of several private companies and one publicly-traded company, Inspire Pharmaceuticals Inc.